Your browser doesn't support javascript.
loading
Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture.
Burckel, Hélène; Josset, Elodie; Denis, Jean-Marc; Gueulette, John; Slabbert, Jakobus; Noël, Georges; Bischoff, Pierre.
Afiliação
  • Burckel H; EA 3430, University of Strasbourg, Centre Paul Strauss, Strasbourg, France.
  • Josset E; EA 3430, University of Strasbourg, Centre Paul Strauss, Strasbourg, France.
  • Denis JM; MIRO, Catholic University of Louvain, Brussels, Belgium.
  • Gueulette J; MIRO, Catholic University of Louvain, Brussels, Belgium.
  • Slabbert J; iThemba LABS, Somerset West, South Africa.
  • Noël G; EA 3430, University of Strasbourg, Centre Paul Strauss, Strasbourg, France.
  • Bischoff P; EA 3430, University of Strasbourg, Centre Paul Strauss, Strasbourg, France.
Oncol Rep ; 33(1): 471-7, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25371289
ABSTRACT
The present in vitro study aimed to assess the effects of combining the mTOR inhibitor RAD001 and temozolomide (TMZ) together with irradiation by either low-linear energy transfer (LET) radiation (γ-rays) or high-LET radiation (fast neutrons) on the growth and cell survival of the human glioblastoma cell line U-87. We observed a strong decrease in cell proliferation along with a concomitant increase in cell death as a function of the radiation dose. As expected, high-LET radiation was more effective and induced more sustained damage to DNA than low-LET radiation. While RAD001 in association with TMZ induced autophagic cell death, additional combination with either type of radiation did not further increase its occurrence. On the contrary, apoptosis remained at a low level in all experimental groups.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article